Skip to main content
. 2021 Dec 15;106(1):261–271. doi: 10.1007/s00253-021-11728-7

Fig. 5.

Fig. 5

Antitumoral activity of SpyADI or SpyADI-PEG20. GBM cells were treated with 35 mU SpyADI or SpyADI-PEG20 for 72 h. Biomass was assessed by Calcein AM staining and absorbance measurement at 570 nm. Absorbance measured for untreated control cells was set to 100% and the other values were related, respectively. Shown are means and standard deviations of n ≥ 3 biological replicates, *p < 0.05, ***p < 0.001, two-way ANOVA